Are We Over-Medicalising Menopause? ⋆ Brownstone Institute

Are We Over-Medicalising Menopause? ⋆ Brownstone Institute

Are We Over-Medicalising Menopause? by Maryanne Demasi at Brownstone Institute On July 15, the FDA convened a two-hour expert panel to review its longstanding guidance on hormone replacement therapy (HRT) for menopause. At first glance, it appeared to be a genuine opportunity to revisit the legacy of the landmark Women’s Health Initiative (WHI), engage with clinical experts, and improve public messaging around hormone treatment. But beneath the …